Who owns CASI PHARMACEUTICALS INC?
- Ticker: CASI
- CUSIP Number: g1933s101
Tip: Access positions for across all investors
Analyze quarterly positions in Casi Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Casi Pharmaceuticals stock
Who bought or sold CASI PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Wellington Shields Capital Management | 133k | $953k | -13% | Dec 2023 |
|
Wellington Shields & Co | 44k | $317k | -40% | Dec 2023 |
|
Franklin Resources | 20k | $144k | 0% | Dec 2023 |
|
Citadel Advisors | 17k | $120k | 100% | Dec 2023 |
|
Jane Street | 13k | $90k | -43% | Dec 2023 |
|
UBS Group | 1.2k | $8.8k | 100% | Dec 2023 |
|
Simplex Trading | 623.00 | $2.0k | 1075% | Mar 2024 |
|
West Paces Advisors | 100.00 | $361.000000 | 0% | Mar 2024 |
|
Cutler | 100.00 | $0 | 100% | Mar 2024 |
|
Jpmorgan Chase & Co | 25.00 | $182.000000 | 0% | Dec 2023 |
|
Mendota Financial Group | 20.00 | $73.000000 | 100% | Mar 2024 |
|
Kozak & Associates | 10.00 | $54.000000 | 0% | Dec 2023 |
|
Wells Fargo & Company | 6.00 | $43.000200 | 0% | Dec 2023 |
|
Bank of America Corporation | 3.00 | $21.000000 | 0% | Dec 2023 |
|
Who sold out of Casi Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Vanguard Group | Sep 2023 | 32k | $83k |
Royal Bank of Canada | Sep 2023 | 18.00 | $0 |